Forum to Discuss Protecting Prison Inmates as Drug Test Subjects CDC Daily UpdateImportant note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




Forum to Discuss Protecting Prison Inmates as Drug Test Subjects

Boston Globe Online (10/11/99) P. A3
Whitaker, Robert


AIDS doctors, ethicists, lawyers, prisoner advocates, and others will meet at Brown University this week to discuss draft recommendations for using prisoners as subjects for a late-stage trials of AIDS drugs. Although there are not very many such trials being conducted at present, physicians and advocates say more should be conducted because drug studies can provide HIV-infected prisoners with better medical treatment. John McFeel, a lawyer on the executive committee of the AIDS Clinical Trials Group, notes that inmates do not have access to drug trials in most states. Participants at the meeting, which is funded in part by Bristol-Myers Squibb, are seeking to ensure that prisoners are not exploited in drug trials, as they were several decades ago.


991011
AD991710


Copyright © 1999 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.